Radius Health Current Ratio 2010-2019 | RDUS

Radius Health current ratio from 2010 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Radius Health Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-12-31 $0.20B $0.06B 3.32
2019-09-30 $0.21B $0.06B 3.80
2019-06-30 $0.23B $0.05B 4.38
2019-03-31 $0.25B $0.05B 5.16
2018-12-31 $0.28B $0.05B 5.92
2018-09-30 $0.26B $0.05B 5.50
2018-06-30 $0.26B $0.05B 5.39
2018-03-31 $0.26B $0.04B 6.55
2017-12-31 $0.27B $0.05B 5.04
2017-09-30 $0.49B $0.04B 12.87
2017-06-30 $0.22B $0.03B 7.04
2017-03-31 $0.29B $0.03B 8.75
2016-12-31 $0.34B $0.03B 10.23
2016-09-30 $0.37B $0.03B 14.76
2016-06-30 $0.41B $0.02B 20.75
2016-03-31 $0.44B $0.02B 23.27
2015-12-31 $0.48B $0.02B 22.68
2015-09-30 $0.51B $0.02B 28.16
2015-06-30 $0.23B $0.02B 11.05
2015-03-31 $0.24B $0.02B 13.35
2014-12-31 $0.11B $0.02B 5.22
2014-09-30 $0.07B $0.03B 2.77
2014-06-30 $0.08B $0.02B 3.83
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B 0.00
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2012-12-31 $0.03B $0.02B 1.47
2011-12-31 $0.06B $0.01B 9.35
2010-12-31 $0.02B $0.00B 5.57
2009-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.582B $0.173B
Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the prevention of fractures in post-menopausal women at risk of fracture from osteoporosis. Radius Health Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.432B 34.96
Takeda Pharmaceutical (TAK) Japan $50.633B 8.87
Astellas Pharma (ALPMY) Japan $28.956B 14.46
Eisai (ESALY) Japan $20.668B 38.50
UCB SA (UCBJF) Belgium $15.687B 0.00
Grifols, S.A (GRFS) Spain $14.019B 17.43
Merck (MKGAF) Germany $12.608B 16.53
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.863B 246.23
Catalent (CTLT) United States $8.068B 33.19
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Ionis Pharmaceuticals (IONS) United States $7.309B 22.15
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.518B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.089B 7.42
Orion OYJ (ORINY) Finland $5.269B 23.61
IPSEN SA ADR (IPSEY) France $4.827B 0.00
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
United Therapeutics (UTHR) United States $4.239B 0.00
Evotec AG (EVTCY) Germany $3.769B 60.79
Hypermarcas (HYPMY) Brazil $3.762B 11.44
Nektar Therapeutics (NKTR) United States $3.274B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.203B 59.45
FibroGen (FGEN) United States $3.096B 0.00
PTC Therapeutics (PTCT) United States $2.765B 0.00
ChemoCentryx (CCXI) United States $2.672B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.451B 9.92
Xencor (XNCR) United States $1.736B 70.91
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.666B 0.00
Sage Therapeutics (SAGE) United States $1.558B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.557B 18.92
USANA Health Sciences (USNA) United States $1.529B 16.05
Theravance Biopharma (TBPH) Cayman Islands $1.481B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.403B 38.38
Corcept Therapeutics (CORT) United States $1.336B 14.95
Karyopharm Therapeutics (KPTI) United States $1.264B 0.00
Heron Therapeutics (HRTX) United States $1.263B 0.00
Zogenix (ZGNX) United States $1.110B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.039B 32.20
Esperion Therapeutics (ESPR) United States $0.990B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.928B 12.92
Akebia Therapeutics (AKBA) United States $0.903B 0.00
Endo (ENDP) Ireland $0.785B 1.45
CLINIGEN GP (CLIGF) United Kingdom $0.771B 0.00
Tilray (TLRY) Canada $0.726B 0.00
Molecular Templates (MTEM) United States $0.666B 0.00
Collegium Pharmaceutical (COLL) United States $0.627B 0.00
Aerie Pharmaceuticals (AERI) United States $0.622B 0.00
ImmunoGen (IMGN) United States $0.608B 0.00
Translate Bio (TBIO) United States $0.595B 0.00
Portola Pharmaceuticals (PTLA) United States $0.543B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.430B 14.35
Siga Technologies (SIGA) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.414B 16.99
Indivior (INVVY) United States $0.397B 2.36
Calithera Biosciences (CALA) United States $0.389B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.379B 0.00
Ardelyx (ARDX) United States $0.376B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.345B 0.00
Trillium Therapeutics (TRIL) Canada $0.345B 0.00
Organogenesis Holdings (ORGO) United States $0.339B 0.00
Flexion Therapeutics (FLXN) United States $0.328B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.322B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.308B 0.00
DURECT (DRRX) United States $0.307B 0.00
Lannett Co Inc (LCI) United States $0.296B 4.76
Harpoon Therapeutics (HARP) United States $0.290B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.289B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.285B 0.00
Concert Pharmaceuticals (CNCE) United States $0.284B 0.00
Ocular Therapeutix (OCUL) United States $0.276B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.265B 0.00
TherapeuticsMD (TXMD) United States $0.263B 0.00
Rafael Holdings (RFL) United States $0.223B 0.00
PROFOUND MEDICL (PROF) Canada $0.194B 0.00
Recro Pharma (REPH) United States $0.189B 0.00
CASI Pharmaceuticals (CASI) United States $0.187B 0.00
OptiNose (OPTN) United States $0.172B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.172B 0.00
MEI Pharma (MEIP) United States $0.165B 0.00
KalVista Pharmaceuticals (KALV) United States $0.157B 0.00
Jounce Therapeutics (JNCE) United States $0.155B 2.80
Nature's Sunshine Products (NATR) United States $0.154B 19.29
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
VAXART, INC (VXRT) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.106B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.105B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.088B 0.00
Aquestive Therapeutics (AQST) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
IMV INC (IMV) Canada $0.084B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.083B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.080B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
Biomerica (BMRA) United States $0.071B 0.00
Hemispherx BioPharma (AIM) United States $0.070B 0.00
Xeris Pharmaceuticals (XERS) United States $0.070B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
CV Sciences (CVSI) United States $0.062B 0.00
Otonomy (OTIC) United States $0.062B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 18.33
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
PharmAthene (ALT) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Aclaris Therapeutics (ACRS) United States $0.048B 0.00
Sundial Growers (SNDL) Canada $0.047B 0.00
GTx (ONCT) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 20.28
Neos Therapeutics (NEOS) United States $0.042B 0.00
MediWound (MDWD) Israel $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 133.29
Forward Pharma (FWP) Denmark $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolarityTE (PTE) United States $0.037B 0.00
Addex Therapeutics (ADXN) Switzerland $0.037B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.034B 0.00
IsoRay (ISR) United States $0.033B 0.00
AgeX Therapeutics (AGE) United States $0.032B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Cardiome Pharma (CORV) Canada $0.024B 0.00
ElectroCore (ECOR) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.022B 0.00
Lipocine (LPCN) United States $0.021B 0.00
Mannatechorporated (MTEX) United States $0.021B 6.58
Bio-Path Holdings (BPTH) United States $0.018B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Novan (NOVN) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Can-Fite Biopharma (CANF) Israel $0.013B 0.00
Shineco (TYHT) China $0.012B 0.00
KemPharm (KMPH) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00